Sai Parenterals says acquisition will add 16 brands to portfolio
In short
Sai Parenterals says its deal to buy a majority stake in Bion will add 16 brands and about 250 field staff.
The company says the purchase will strengthen its position in India’s prescription market.
What the reporting says
Sai Parenterals said its acquisition of a majority stake in Bion will add 16 established brands and around 250 field staff. The company said the deal will strengthen its presence in India’s prescription market. The announcement highlights a growth move for Sai Parenterals in the domestic pharma market.
Why it matters
Sai Parenterals said its acquisition of a majority stake in Bion will add 16 established brands and around 250 field staff. The company says the move will strengthen its presence in India’s prescription market, indicating a broader push in pharmaceuticals.